EX-24 6 impl-ex24_1.htm EX-24.1 EX-24

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Seattle, State of Washington, on this 27th day of March, 2023.

 

IMPEL PHARMACEUTICALS INC.

 

By: /s/ Adrian Adams

Adrian Adams

President and Chief Executive Officer

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Adrian Adams and Rajiv Amin, and each of them, as his or her true and lawful attorney-in-fact and agent with full power of substitution, for him or her in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

 

Signature

 

Title

 

Date

 

/s/ Adrian Adams

 

Chief Executive Officer and Director

March 27, 2023

 

Adrian Adams

 

(Principal Executive Officer)

 

 

 

/s/ Rajiv Amin

 

 

Interim Chief Financial Officer

 

March 27, 2023

 

Rajiv Amin

 

(Principal Financial Officer and Principal Accounting Officer)

 

 

 

/s/ David Allison

 

 

 

Director

 

March 27, 2023

 

David Allison

 

 

 

 

 

 

 

 

 

/s/ Timothy S. Nelson

 

 

Director

March 27, 2023

 

Timothy S. Nelson

 

 

 

 

 

 

 

 

 

/s/ H. Stewart Parker

 

 

Director

March 27, 2023

 

H. Stewart Parker

 

 

 

 

 

 

 

 

 

/s/ Ali Satvat

 

 

Director

March 27, 2023

 

Ali Satvat

 

 

 

 

 

 

 

 

 

/s/ Mahendra G. Shah

 

 

Director

March 27, 2023

 

Mahendra G. Shah

 

 

 

 

 

 

 

 

 

/s/ Diane E. Wilfong

 

 

Director

March 27, 2023

 

Diane E. Wilfong